Antiparkinsonian medication masks motor signal progression in de novo patients
Journal article
Brzezicki MA. et al, (2023), Heliyon, e16415 - e16415
Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers
Journal article
Garces P. et al, (2023), The Cerebellum
Quantitative Oculomotor Assessment in Hereditary Ataxia: Discriminatory Power, Correlation with Severity Measures, and Recommended Parameters for Specific Genotypes
Journal article
Garces P. et al, (2023), The Cerebellum
Longitudinal monitoring of Progressive Supranuclear Palsy using Body-Worn movement sensors
Journal article
ANTONIADES C. and FITZGERALD J., (2022), MDS
Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches
Journal article
Bredemeyer O. et al, (2022), Frontiers in Digital Health, 4
Deep Brain Stimulation and Levodopa Affect Gait Variability in Parkinson Disease Differently
Journal article
Su ZH. et al, (2022), Neuromodulation: Technology at the Neural Interface
Art Exists Because the Viewer Exists How François Morellet’s Triple X Neonly Influences Postural Control and Subjective Aesthetic Appreciation
Journal article
Ward LM. et al, (2022), Leonardo, 55, 48 - 50
Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
Journal article
Pereira MF. et al, (2022), BMJ Neurology Open, 4, e000214 - e000214
Parkinson's disease deficits in time perception to auditory as well as visual stimuli - A large online study.
Journal article
Su ZH. et al, (2022), Front Neurosci, 16
Strategy Adherence: A Specific and Rapidly Progressive Deficit in Progressive Supranuclear Palsy
Journal article
Brzezicki MA. et al, (2021), Movement Disorders Clinical Practice, 8, 1272 - 1274
Supranuclear gaze disorders - How do I approach them?
Conference paper
Antoniades C., (2021), JOURNAL OF THE NEUROLOGICAL SCIENCES, 429
Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort - the OxQUIP study
Conference paper
Pereira M. and Antoniades C., (2021), MOVEMENT DISORDERS, 36, S254 - S254
Novel Cognitive Markers for Early Diagnosis and Monitoring of Progressive Supranuclear Palsy
Conference paper
Brzezicki M. and Antoniades C., (2021), MOVEMENT DISORDERS, 36, S251 - S251
Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning
Journal article
De Vos M. et al, (2020), Gait & Posture, 77, 257 - 263
The effect of levodopa on saccades – Oxford Quantification in Parkinsonism study
Journal article
Lu Z. et al, (2019), Parkinsonism & Related Disorders, 68, 49 - 56
Oculomotor effects of medical and surgical treatments of Parkinson's disease.
Journal article
ANTONIADES C. and FITZGERALD J., (2019), Progress in Brain Research
Quantifying eye and gait abnormalities in Parkinson's patients after Deep brain stimulation
Conference paper
Su Z. et al, (2019), MOVEMENT DISORDERS, 34
Oculomotor effects of medical and surgical treatments of Parkinson's disease.
Chapter
Patel S. et al, (2019), 249, 297 - 305
The Influence of Deep Brain Stimulation on Eye Movements
Chapter
Patel S. et al, (2019), ADVANCES IN TRANSLATIONAL NEUROSCIENCE OF EYE MOVEMENT DISORDERS, 377 - 387